3-day course of ofloxacin versus cefalexin in the treatment of urinary tract infections in postmenopausal women.
Raz
R
R
Infectious Diseases Unit, Central Emek Hospital, Afula, Israel.
Rozenfeld
S
S
D000368:Aged; D000892:Anti-Infective Agents, Urinary / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002506:Cephalexin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002511:Cephalosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003365:Costs and Cost Analysis; D005260:Female; D006801:Humans; D008875:Middle Aged; D015242:Ofloxacin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017698:Postmenopause; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000191:economics / Q000382:microbiology
D000892:Anti-Infective Agents, Urinary; D002511:Cephalosporins; D015242:Ofloxacin; D002506:Cephalexin